Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
Related Posts
Elon Musk gets more time to respond to SEC suit over Twitter disclosure
Musk now has until Aug. 29, an additional six weeks, to answer the SEC’s complaint.
‘Weak and pathetic’: Trump seethes as Mark Cuban campaigns for Harris
Mark Cuban has become a regular surrogate for Vice President Kamala Harris in the race against Donald Trump.
Millions across Midwest and South reeling from widespread flooding as storm death toll rises to 21
As many as 9 million people are under a flood watch across portions of Georgia and eastern Alabama.